Concord Control Systems Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 29, 2025, 8:08 pm

Quick Insight

Concord Control Systems Ltd, operating in the heavy engineering industry, presents a mixed picture for investors. With a current share price of 2,000 and a market capitalization of 1,260 Cr., the stock seems overvalued with a high P/E ratio of 55.6. However, the company's impressive Return on Equity (ROE) at 27.4% and Return on Capital Employed (ROCE) at 36.8% indicate strong profitability. Furthermore, a healthy Operating Profit Margin (OPM) of 20% and a comfortable Interest Coverage Ratio (ICR) of 13.11x suggest financial stability. Investors should closely monitor the company's ability to manage its working capital, as reflected in a high Cash Conversion Cycle (CCC) of 265 days. In conclusion, while Concord Control Systems Ltd shows promise in terms of profitability, its high valuation and working capital efficiency warrant careful consideration before investment.

Competitors of Concord Control Systems Ltd

All Competitor Stocks of Concord Control Systems Ltd

Quarterly Result

Last Updated: May 31, 2025, 6:27 am

Below is a detailed analysis of the quarterly data for Concord Control Systems Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 75.00 Cr.. The value appears strong and on an upward trend. It has increased from 50.00 Cr. (Sep 2024) to 75.00 Cr., marking an increase of 25.00 Cr..
• For Expenses, as of Mar 2025, the value is 60.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 36.00 Cr. (Sep 2024) to 60.00 Cr., marking an increase of 24.00 Cr..
• For Operating Profit, as of Mar 2025, the value is 15.00 Cr.. The value appears strong and on an upward trend. It has increased from 14.00 Cr. (Sep 2024) to 15.00 Cr., marking an increase of 1.00 Cr..
• For OPM %, as of Mar 2025, the value is 20.00%. The value appears to be declining and may need further review. It has decreased from 28.00% (Sep 2024) to 20.00%, marking a decrease of 8.00%.
• For Other Income, as of Mar 2025, the value is 2.00 Cr.. The value appears strong and on an upward trend. It has increased from 1.00 Cr. (Sep 2024) to 2.00 Cr., marking an increase of 1.00 Cr..
• For Interest, as of Mar 2025, the value is 0.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2.00 Cr. (Sep 2024) to 0.00 Cr., marking a decrease of 2.00 Cr..
• For Depreciation, as of Mar 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 1.00 Cr..
• For Profit before tax, as of Mar 2025, the value is 16.00 Cr.. The value appears strong and on an upward trend. It has increased from 12.00 Cr. (Sep 2024) to 16.00 Cr., marking an increase of 4.00 Cr..
• For Tax %, as of Mar 2025, the value is 14.00%. The value appears to be improving (decreasing) as expected. It has decreased from 29.00% (Sep 2024) to 14.00%, marking a decrease of 15.00%.
• For Net Profit, as of Mar 2025, the value is 14.00 Cr.. The value appears strong and on an upward trend. It has increased from 8.00 Cr. (Sep 2024) to 14.00 Cr., marking an increase of 6.00 Cr..
• For EPS in Rs, as of Mar 2025, the value is 22.82. The value appears strong and on an upward trend. It has increased from 13.84 (Sep 2024) to 22.82, marking an increase of 8.98.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 2:07 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 1:32 pm

Below is a detailed analysis of the balance sheet data for Concord Control Systems Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 6.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 6.00 Cr..
• For Reserves, as of Mar 2025, the value is 113.00 Cr.. The value appears strong and on an upward trend. It has increased from 40.00 Cr. (Mar 2024) to 113.00 Cr., marking an increase of 73.00 Cr..
• For Borrowings, as of Mar 2025, the value is 0.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 3.00 Cr. (Mar 2024) to 0.00 Cr., marking a decrease of 3.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 16.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 11.00 Cr. (Mar 2024) to 16.00 Cr., marking an increase of 5.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 136.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 60.00 Cr. (Mar 2024) to 136.00 Cr., marking an increase of 76.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 23.00 Cr.. The value appears strong and on an upward trend. It has increased from 3.00 Cr. (Mar 2024) to 23.00 Cr., marking an increase of 20.00 Cr..
• For CWIP, as of Mar 2025, the value is 1.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2024) to 1.00 Cr., marking an increase of 1.00 Cr..
• For Investments, as of Mar 2025, the value is 7.00 Cr.. The value appears strong and on an upward trend. It has increased from 4.00 Cr. (Mar 2024) to 7.00 Cr., marking an increase of 3.00 Cr..
• For Other Assets, as of Mar 2025, the value is 105.00 Cr.. The value appears strong and on an upward trend. It has increased from 53.00 Cr. (Mar 2024) to 105.00 Cr., marking an increase of 52.00 Cr..
• For Total Assets, as of Mar 2025, the value is 136.00 Cr.. The value appears strong and on an upward trend. It has increased from 60.00 Cr. (Mar 2024) to 136.00 Cr., marking an increase of 76.00 Cr..

Notably, the Reserves (113.00 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Key Financial Ratios

After reviewing the key financial ratios for Concord Control Systems Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 37.13. This value is within the healthy range. It has increased from 21.97 (Mar 24) to 37.13, marking an increase of 15.16.
• For Diluted EPS (Rs.), as of Mar 25, the value is 37.13. This value is within the healthy range. It has increased from 21.97 (Mar 24) to 37.13, marking an increase of 15.16.
• For Cash EPS (Rs.), as of Mar 25, the value is 39.43. This value is within the healthy range. It has increased from 22.69 (Mar 24) to 39.43, marking an increase of 16.74.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 189.17. It has increased from 77.21 (Mar 24) to 189.17, marking an increase of 111.96.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 189.17. It has increased from 77.21 (Mar 24) to 189.17, marking an increase of 111.96.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 197.54. It has increased from 109.52 (Mar 24) to 197.54, marking an increase of 88.02.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 52.62. This value is within the healthy range. It has increased from 30.54 (Mar 24) to 52.62, marking an increase of 22.08.
• For PBIT / Share (Rs.), as of Mar 25, the value is 49.99. This value is within the healthy range. It has increased from 29.65 (Mar 24) to 49.99, marking an increase of 20.34.
• For PBT / Share (Rs.), as of Mar 25, the value is 45.97. This value is within the healthy range. It has increased from 29.41 (Mar 24) to 45.97, marking an increase of 16.56.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 36.79. This value is within the healthy range. It has increased from 21.80 (Mar 24) to 36.79, marking an increase of 14.99.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 35.96. This value is within the healthy range. It has increased from 21.41 (Mar 24) to 35.96, marking an increase of 14.55.
• For PBDIT Margin (%), as of Mar 25, the value is 26.63. This value is within the healthy range. It has decreased from 27.88 (Mar 24) to 26.63, marking a decrease of 1.25.
• For PBIT Margin (%), as of Mar 25, the value is 25.30. This value exceeds the healthy maximum of 20. It has decreased from 27.07 (Mar 24) to 25.30, marking a decrease of 1.77.
• For PBT Margin (%), as of Mar 25, the value is 23.27. This value is within the healthy range. It has decreased from 26.85 (Mar 24) to 23.27, marking a decrease of 3.58.
• For Net Profit Margin (%), as of Mar 25, the value is 18.62. This value exceeds the healthy maximum of 10. It has decreased from 19.90 (Mar 24) to 18.62, marking a decrease of 1.28.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 18.20. This value is within the healthy range. It has decreased from 19.54 (Mar 24) to 18.20, marking a decrease of 1.34.
• For Return on Networth / Equity (%), as of Mar 25, the value is 19.00. This value is within the healthy range. It has decreased from 27.73 (Mar 24) to 19.00, marking a decrease of 8.73.
• For Return on Capital Employeed (%), as of Mar 25, the value is 26.00. This value is within the healthy range. It has decreased from 37.89 (Mar 24) to 26.00, marking a decrease of 11.89.
• For Return On Assets (%), as of Mar 25, the value is 16.65. This value is within the healthy range. It has decreased from 21.26 (Mar 24) to 16.65, marking a decrease of 4.61.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. It has decreased from 0.05 (Mar 24) to 0.00, marking a decrease of 0.05.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.27. It has decreased from 1.46 (Mar 24) to 1.27, marking a decrease of 0.19.
• For Current Ratio (X), as of Mar 25, the value is 6.45. This value exceeds the healthy maximum of 3. It has increased from 3.58 (Mar 24) to 6.45, marking an increase of 2.87.
• For Quick Ratio (X), as of Mar 25, the value is 3.92. This value exceeds the healthy maximum of 2. It has increased from 3.34 (Mar 24) to 3.92, marking an increase of 0.58.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 3.64. This value is below the healthy minimum of 4. It has decreased from 12.35 (Mar 24) to 3.64, marking a decrease of 8.71.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 13.11. This value is within the healthy range. It has decreased from 125.55 (Mar 24) to 13.11, marking a decrease of 112.44.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 10.16. This value is within the healthy range. It has decreased from 90.64 (Mar 24) to 10.16, marking a decrease of 80.48.
• For Enterprise Value (Cr.), as of Mar 25, the value is 690.46. It has increased from 349.29 (Mar 24) to 690.46, marking an increase of 341.17.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 5.55. This value exceeds the healthy maximum of 3. It has increased from 5.33 (Mar 24) to 5.55, marking an increase of 0.22.
• For EV / EBITDA (X), as of Mar 25, the value is 20.83. This value exceeds the healthy maximum of 15. It has increased from 19.12 (Mar 24) to 20.83, marking an increase of 1.71.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 5.66. This value exceeds the healthy maximum of 3. It has increased from 5.65 (Mar 24) to 5.66, marking an increase of 0.01.
• For Price / BV (X), as of Mar 25, the value is 5.92. This value exceeds the healthy maximum of 3. It has decreased from 8.02 (Mar 24) to 5.92, marking a decrease of 2.10.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 5.66. This value exceeds the healthy maximum of 3. It has increased from 5.65 (Mar 24) to 5.66, marking an increase of 0.01.
• For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.03.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness